Skip to main content
. 2017 Nov 7;17(2):477–485. doi: 10.1177/1534735417734913

Figure 2.

Figure 2.

Cumulative overall survival rates of patients in TACE + KA and TACE groups (P = .038 by log-rank test). TACE, transarterial chemoembolization; KA, Kang’ai injection.